Regeneron Pharmaceuticals
REGN
#279
Rank
NZ$136.06 B
Marketcap
NZ$1,284
Share price
2.84%
Change (1 day)
-3.22%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$15.83 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are NZ$15.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$14.90 B32.62%
2023-12-31NZ$11.23 B8.93%
2022-12-31NZ$10.31 B5.72%
2021-12-31NZ$9.75 B14.72%
2020-12-31NZ$8.50 B54.2%
2019-12-31NZ$5.51 B24.3%
2018-12-31NZ$4.43 B20.3%
2017-12-31NZ$3.68 B1.24%
2016-12-31NZ$3.64 B27.62%
2015-12-31NZ$2.85 B73.78%
2014-12-31NZ$1.64 B35.17%
2013-12-31NZ$1.21 B19.75%
2012-12-31NZ$1.01 B-5.44%
2011-12-31NZ$1.07 B47.47%
2010-12-31NZ$0.72 B53.51%
2009-12-31NZ$0.47 B-9.09%
2008-12-31NZ$0.52 B-16.06%
2007-12-31NZ$0.62 B18.81%
2006-12-31NZ$0.52 B15.5%
2005-12-31NZ$0.45 B11.2%
2004-12-31NZ$0.40 B-22.58%
2003-12-31NZ$0.52 B12.08%
2002-12-31NZ$0.46 B-14.92%
2001-12-31NZ$0.55 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$138.42 B 774.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$7.93 B-49.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.91 B 19.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$195.18 B 1,132.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$107.50 B 578.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$113.50 B 616.78%๐Ÿ‡ซ๐Ÿ‡ท France